Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.4K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K
Vaccines01:21

Vaccines

49
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
49
Cancer Vaccines01:30

Cancer Vaccines

1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Degradation of the pyrethroid insecticide dimefluthrin in a water-sediment system: detailed insight into the non-extractable residues.

Journal of pesticide science·2026
Same author

Degradation of the anilide fungicide inpyrfluxam in illuminated water-sediment systems.

Journal of pesticide science·2025
Same author

Impact of Viral Diseases on the Livestock Sector in Bangladesh.

Veterinary medicine international·2025
Same author

Meta-analysis of genetic diversity of VP1 gene of foot and mouth disease virus serotypes prevalent in Bangladesh from 2010 to 2024.

Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases·2025
Same author

Molecular Characterization, Antibiogram, and Virulence Gene Profiling of Proteus vulgaris Isolated From Cattle With Bovine Respiratory Disease in Bangladesh.

Veterinary medicine and science·2025
Same author

Response-guided Strategy Based on Induction Chemotherapy Without Routine Use of Radiotherapy for Locally Advanced Rectal Cancer.

Anticancer research·2025

Related Experiment Video

Updated: Apr 4, 2026

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.9K

Developments in Viral Vector-Based Vaccines.

Takehiro Ura1, Kenji Okuda1, Masaru Shimada2

  • 1Department of Molecular Biodefense Research, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa Prefecture 236-0004, Japan.

Vaccines
|September 8, 2015
PubMed
Summary

Viral vectors are key for gene therapy and vaccines, offering enhanced immune responses. This review covers major viral vectors for clinical use, detailing their risks, benefits, and trial outcomes.

Keywords:
CTLMVAadenovirusvaccineviral vector

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.4K
Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

23.0K

Related Experiment Videos

Last Updated: Apr 4, 2026

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.9K
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.4K
Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

23.0K

Area of Science:

  • * Virology
  • * Immunology
  • * Gene Therapy

Background:

  • * Viral vectors are crucial for developing advanced gene therapies and vaccines.
  • * They can boost immunogenicity and cytotoxic T lymphocyte (CTL) responses, aiding in eliminating infected cells.
  • * Numerous viral vectors have been engineered, each with distinct advantages and risks.

Purpose of the Study:

  • * To review and highlight the most suitable viral vectors for clinical applications.
  • * To discuss the evolution of viral vectors, including genetic modifications for improved efficacy and safety.
  • * To summarize key findings from clinical trials regarding toxicity, dosage, and vaccination strategies.

Main Methods:

  • * Comprehensive literature review of viral vector development and clinical trial data.
  • * Analysis of viral vector characteristics, including immunogenicity and safety profiles.
  • * Evaluation of genetically modified vectors for enhanced performance and manufacturability.

Main Results:

  • * Various viral vectors have been developed, each possessing unique attributes and associated risks.
  • * Clinical trials have yielded both successful and unsuccessful outcomes, providing critical data.
  • * Genetically altered vectors show potential for improved efficacy, safety, and scalability.

Conclusions:

  • * Viral vectors represent a significant advancement in vaccine and gene therapy development.
  • * Understanding vector-specific risks and benefits is crucial for successful clinical translation.
  • * Ongoing research and clinical trials continue to refine viral vector technology for optimal patient outcomes.